We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Lab Evidence Confirms Outbreak of Haff Disease

By LabMedica International staff writers
Posted on 28 Jun 2017
Haff disease is a syndrome of unexplained rhabdomyolysis following consumption of certain types of fish, and it is caused by an unidentified toxin. More...
Rhabdomyolysis is a clinical syndrome caused by injury to skeletal muscle that results in release of muscle cell contents into the circulation.

Cases of Haff disease were first described in 1924, in the Baltic region of Prussia and Sweden and involved the consumption of different cooked freshwater fish, such as burbot, pike and freshwater eel. In the USA, the first cases of Haff disease were reported in Texas in 1984, and six additional cases of Haff disease were reported in patients from California and Missouri, who had eaten buffalo fish.

A team of Brazilian scientists led by those at the Faculdade de Tecnologia e Ciencias Medical School (Salvador, Brazil) have presented data on an a series of 15 Haff disease cases from an outbreak in Salvador, Brazil, starting early December 2016. Eleven cases were grouped in four family clusters of two to four individuals, and four were isolated cases. The investigators reported that all but one of the patient consumed cooked fish; 11 within 24 hours before symptoms onset. Cases consumed ‘Olho de Boi’ (Seriola spp.) and ’Badejo’ (Mycteroperca spp.). A total of 67 cases were detected, the last case was reported on April 5, 2017.

The scientists performed serial measurements of muscle enzymes, such as creatine phosphokinase (CPK), aspartate aminotransferase (AST), alanine aminotransferase (ALT) and lactate dehydrogenase (LDH) in all patients. In addition, troponin I levels and creatine kinase-MB (CK-MB) fractions were measured in three and two cases, respectively. They screened 10 patients for chikungunya and Zika virus RNA. Sequencing was performed by a sequencing facility using the ABI-Prism 3500 genetic analyzer.

The team found that CPK levels at presentation ranged from 743 to 105,755 U/L, which was extremely elevated, and decreased rapidly on subsequent days in parallel with the improvement of symptoms. Troponin I levels were less than 0.034 ng/mL in all patients with measurements. CK-MB fraction ranged from 1.9% to 6.3%. Reverse transcription polymerase chain reaction (RT-PCR) for chikungunya and Zika viruses, as well as nested RT-PCR for parechovirus, yielded negative results for all patients in all types of samples. The RT-PCR for enterovirus generated non-specific products in four samples. However, upon analysis of the sequenced fragments no virus could be identified.

The authors concluded that it is important for travel medicine physicians to be alert in case of patients returning from Salvador, Brazil, with myalgia and symptoms of rhabdomyolysis to consider Haff disease as a possible differential diagnosis. Care should also be taken when treating these patients so as to avoid non-steroidal anti-inflammatory agents because of possible concurrent renal toxicity. The study was published on June 15, 2017, in the journal Eurosurveillance.

Related Links:
Faculdade de Tecnologia e Ciencias Medical School


Gold Member
Blood Gas Analyzer
Stat Profile pHOx
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Silver Member
PCR Plates
Diamond Shell PCR Plates
Gold Member
Ketosis and DKA Test
D-3-Hydroxybutyrate (Ranbut) Assay
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: LiDia-SEQ aims to deliver near-patient NGS testing capabilities to hospitals, labs and clinics (Photo courtesy of DNAe)

World's First NGS-Based Diagnostic Platform Fully Automates Sample-To-Result Process Within Single Device

Rapid point-of-need diagnostics are of critical need, especially in the areas of infectious disease and cancer testing and monitoring. Now, a direct-from-specimen platform that performs genomic analysis... Read more

Hematology

view channel
Image: Residual leukemia cells may predict long-term survival in acute myeloid leukemia (Photo courtesy of Shutterstock)

MRD Tests Could Predict Survival in Leukemia Patients

Acute myeloid leukemia is an aggressive blood cancer that disrupts normal blood cell production and often relapses even after intensive treatment. Clinicians currently lack early, reliable markers to predict... Read more

Pathology

view channel
Image: The AI tool advances precision diagnostics by linking genetic mutations directly to disease types (Photo courtesy of Shutterstock)

AI Tool Simultaneously Identifies Genetic Mutations and Disease Type

Interpreting genetic test results remains a major challenge in modern medicine, particularly for rare and complex diseases. While existing tools can indicate whether a genetic mutation is harmful, they... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.